| HOME >> BIOLOGY >> TECHNOLOGY |
RALEIGH, N.C., and LONDON, May 14 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Gary Tyson, Senior Vice President of the firm's Clinical Development Practice, will present a session on managing the global rollout of electronic data capture (EDC) systems at Informa's Clinical Trials Congress, Europe. The event will be held on May 28-29, 2008, at the Olympia Conference Centre in London.
Mr. Tyson's session, titled "After EDC Implementation: Now What?" is
slated for 29 May at 14:50. The session, designed to help clinical leaders
understand how organizations can ensure successful uptake of EDC solutions
and maximize returns on EDC investments, will cover
-- Performing required organizational changes
-- Implementing continuous process improvement
-- Integrating reporting systems for serious adverse events
-- Integrating other e-clinical systems with EDC
"Although the initial rollout of a clinical EDC solution can be cause for celebration, it doesn't mean that the work is over," Mr. Tyson said. "To fully realize the potential benefits of EDC, clinical organizations must properly integrate key activities and processes with the system."
As head of Campbell Alliance's Clinical Development Practice, Gary Tyson leads a team that provides a range of operational improvement services to clinical development organizations within pharmaceutical and biotech companies, as well as leading contract research organizations (CROs). Mr. Tyson is a veteran of numerous EDC-related initiatives, including helping organizations adopt EDC at the enterprise level, and brings a wealth of knowledge and experience in process improvement, organizational design, and clinical development to his consulting engagements.
For more information on Informa's Clinical Trials Congress, Europe,
please visit
| SOURCE Campbell Alliance Copyright©2008 PR Newswire. All rights reserved |